There are 2137 resources available
898P - T-cell lymphomas (TCL): Real-world experience analysis from cancer registry
Presenter: Marina Puchinskaya
Session: E-Poster Display
Resources:
Abstract
899P - Pharmacoeconomic assessment of subcutaneous retuximab formulation compared to intravenous retuximab in NHL and CLL patients: A single institution experience
Presenter: Sherif Ahmed Mohamed
Session: E-Poster Display
Resources:
Abstract
900P - The emerging treatment options of plasmablastic lymphoma: Analysis of 173 individual patients’ outcomes
Presenter: Nafie Makady
Session: E-Poster Display
Resources:
Abstract
901P - Matching-adjusted indirect comparisons (MAIC) of safety between single-agent belantamab mafodotin versus selinexor plus dexamethasone in relapsed/refractory multiple myeloma (RRMM)
Presenter: Attaya Suvannasankha
Session: E-Poster Display
Resources:
Abstract
902P - Quality of life and response to treatment with ixazomib-lenalidomide-dexamethasone (IRd) in patients with relapsed/refractory multiple myeloma (RRMM) in a real-world setting
Presenter: Tatiana Ionova
Session: E-Poster Display
Resources:
Abstract
903P - Combination of nivolumab with brentuximab vedotin in therapy of relapsed and refractory Hodgkin lymphoma
Presenter: Liudmila Fedorova
Session: E-Poster Display
Resources:
Abstract
904P - The role of arginine/citrulline cycle disorders in the liver injury pathogenesis in acute myeloid leukemia patients with concomitant obesity
Presenter: Ganna Maslova
Session: E-Poster Display
Resources:
Abstract
909P - Efficacy and safety of HHPG-19K for prophylaxis of chemotherapy-induced neutropenia in patients with lymphoma
Presenter: Meijing Zheng
Session: E-Poster Display
Resources:
Abstract
920P - Avelumab (anti-PD-L1) in patients with platinum-refractory/ineligible recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Results from a phase Ib cohort
Presenter: Joel Guigay
Session: E-Poster Display
Resources:
Abstract
921P - Pembrolizumab plus docetaxel for the treatment of recurrent metastatic head and neck cancer: A prospective phase I/II study
Presenter: Thorsten Fuereder
Session: E-Poster Display
Resources:
Abstract